MLP-PSO Hybrid Algorithm for Heart Disease Prediction.

J Pers Med

Department of Nursing, College of Nursing and Health Sciences, The University of Vermont, Burlington, VT 05405, USA.

Published: July 2022

Background: Machine Learning (ML) is becoming increasingly popular in healthcare, particularly for improving the timing and accuracy of diagnosis. ML can provide disease prediction by analyzing vast amounts of healthcare data, thereby, empowering patients and healthcare providers with information to make informed decisions about disease prevention. Due to the rising cost of treatment, one of the most important topics in clinical data analysis is the prediction and prevention of cardiovascular disease. It is difficult to manually calculate the chances of developing heart disease due to a myriad of contributing factors.

Objective: The aim of this paper is to develop and compare various intelligent systems built with ML algorithms for predicting whether a person is likely to develop heart disease using the publicly available Cleveland Heart Disease dataset. This paper describes an alternative multilayer perceptron (MLP) training technique that utilizes a particle swarm optimization (PSO) algorithm for heart disease detection.

Methods: The proposed MLP-PSO hybrid algorithm and ten different ML algorithms are used in this study to predict heart disease. Various classification metrics are used to evaluate the performance of the algorithms.

Results: The proposed MLP-PSO outperforms all other algorithms, obtaining an accuracy of 84.61%.

Conclusions: According to our findings, the current MLP-PSO classifier enables practitioners to diagnose heart disease earlier, more accurately, and more effectively.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394266PMC
http://dx.doi.org/10.3390/jpm12081208DOI Listing

Publication Analysis

Top Keywords

heart disease
28
disease
10
mlp-pso hybrid
8
hybrid algorithm
8
algorithm heart
8
disease prediction
8
proposed mlp-pso
8
heart
7
mlp-pso
4
prediction background
4

Similar Publications

Background: There are insufficient studies to determine whether sodium-glucose cotransporter type 2 inhibitors (SGLT2i) will help reduce early diabetic cardiomyopathy, especially in patients without documented cardiovascular disease.

Methods: We performed a single center, prospective observation study. A total of 90 patients with type 2 diabetes patients without established heart failure or atherosclerotic cardiovascular disease were enrolled.

View Article and Find Full Text PDF

Extracellular vesicles (EVs) are widely investigated for their implications in cell-cell signaling, immune modulation, disease pathogenesis, cancer, regenerative medicine, and as a potential drug delivery vector. However, maintaining integrity and bioactivity of EVs between Good Manufacturing Practice separation/filtration and end-user application remains a consistent bottleneck towards commercialization. Milk-derived extracellular vesicles (mEVs), separated from bovine milk, could provide a relatively low-cost, scalable platform for large-scale mEV production; however, the reliance on cold supply chain for storage remains a logistical and financial burden for biologics that are unstable at room temperature.

View Article and Find Full Text PDF

Improving prognostic evaluations in patients with stage IIIb light chain cardiac amyloidosis: role of haemodynamic parameters.

Orphanet J Rare Dis

January 2025

Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing, 100730, China.

Background: There is no unified prognostic scoring system for light chain cardiac amyloidosis (AL-CA), particularly stage IIIb AL-CA. This study aimed to use invasive haemodynamic information to investigate markers that can more accurately evaluate the prognosis of patients with stage IIIb AL-CA.

Methods: In this retrospective cohort study, we conducted invasive haemodynamic measurements concurrently with myocardial biopsies to diagnose AL-CA.

View Article and Find Full Text PDF

Association between triglyceride-glucose (TyG) related indices and cardiovascular diseases and mortality among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study of UK Biobank.

Cardiovasc Diabetol

January 2025

Medical Big Data Center, Department of General Medicine, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, No. 26 Daoqian Street, Suzhou, 215001, Jiangsu, China.

Background: Triglyceride-glucose (TyG) related indices, which serve as simple markers for insulin resistance, have been closely linked to metabolic dysfunction-associated steatotic liver disease (MASLD), cardiovascular disease (CVD), and mortality. However, the prognostic utility of TyG-related indices in predicting the risk of CVD and mortality among patients with MASLD remains unclear.

Methods: Data of 97,331 MASLD patients, with a median age of 58.

View Article and Find Full Text PDF

Background: Unlike non-rheumatic atrial fibrillation (AF), where left atrial thrombus (LAT) is predominantly confined to the left atrial appendage (LAA), a significant proportion of LAT in rheumatic AF occurs within the left atrial cavity (LAC). However, LAC thrombosis in rheumatic AF has not been extensively studied. This study aimed to evaluate the prevalence of LAT and its subtypes and identify potential predictors of LAT.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!